Fixed or Self-Titrated Dosages of Sativex on Cannabis Users
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to to demonstrate the feasibility and tolerability of the use of
Sativex in cannabis dependent individuals and to assess the effects of fixed or self titrated
dosages of SATIVEX® (Δ9-tetrahydrocannabinol /cannabidiol combination in a buccal spray) on
withdrawal symptoms, craving scores and cannabis consumption during the study period.